Ambica Agarbathies Aroma & Industries Limited
Ambica Agarbathies Aroma & Industries Limited (AMBICAAGAR.BO) Stock Competitors & Peer Comparison
See (AMBICAAGAR.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMBICAAGAR.BO | ₹24.00 | +0.42% | 412.3M | 82.76 | ₹0.29 | N/A |
| HINDUNILVR.NS | ₹2,198.40 | -0.50% | 5.2T | 48.67 | ₹45.17 | +1.96% |
| HINDUNILVR.BO | ₹2,197.85 | -0.53% | 5.2T | 47.53 | ₹46.24 | +1.96% |
| MARICO.NS | ₹833.80 | +0.46% | 1.1T | 61.26 | ₹13.61 | +0.84% |
| MARICO.BO | ₹833.80 | +0.46% | 1.1T | 63.17 | ₹13.20 | +0.84% |
| GODREJCP.BO | ₹1,044.45 | +1.19% | 1.1T | 58.64 | ₹17.81 | +1.91% |
| GODREJCP.NS | ₹1,044.40 | +1.22% | 1.1T | 57.42 | ₹18.19 | +1.91% |
| DABUR.NS | ₹445.45 | -0.48% | 790.1B | 41.83 | ₹10.65 | +1.80% |
| DABUR.BO | ₹445.35 | -0.56% | 789.9B | 42.95 | ₹10.37 | +1.80% |
| COLPAL.NS | ₹2,087.40 | +0.50% | 567.7B | 42.77 | ₹48.81 | +2.44% |
Stock Comparison
AMBICAAGAR.BO vs HINDUNILVR.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, HINDUNILVR.NS has a market cap of 5.2T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while HINDUNILVR.NS trades at ₹2,198.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas HINDUNILVR.NS's P/E ratio is 48.67. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HINDUNILVR.NS's ROE of +0.31%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to HINDUNILVR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HINDUNILVR.NS's competition here
AMBICAAGAR.BO vs HINDUNILVR.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, HINDUNILVR.BO has a market cap of 5.2T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while HINDUNILVR.BO trades at ₹2,197.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas HINDUNILVR.BO's P/E ratio is 47.53. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HINDUNILVR.BO's ROE of +0.31%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to HINDUNILVR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HINDUNILVR.BO's competition here
AMBICAAGAR.BO vs MARICO.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, MARICO.NS has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while MARICO.NS trades at ₹833.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas MARICO.NS's P/E ratio is 61.26. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to MARICO.NS's ROE of +0.43%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to MARICO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check MARICO.NS's competition here
AMBICAAGAR.BO vs MARICO.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, MARICO.BO has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while MARICO.BO trades at ₹833.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas MARICO.BO's P/E ratio is 63.17. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to MARICO.BO's ROE of +0.43%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to MARICO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check MARICO.BO's competition here
AMBICAAGAR.BO vs GODREJCP.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, GODREJCP.BO has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while GODREJCP.BO trades at ₹1,044.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas GODREJCP.BO's P/E ratio is 58.64. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to GODREJCP.BO's ROE of +0.15%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to GODREJCP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check GODREJCP.BO's competition here
AMBICAAGAR.BO vs GODREJCP.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, GODREJCP.NS has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while GODREJCP.NS trades at ₹1,044.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas GODREJCP.NS's P/E ratio is 57.42. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to GODREJCP.NS's ROE of +0.15%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to GODREJCP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check GODREJCP.NS's competition here
AMBICAAGAR.BO vs DABUR.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, DABUR.NS has a market cap of 790.1B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while DABUR.NS trades at ₹445.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas DABUR.NS's P/E ratio is 41.83. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to DABUR.NS's ROE of +0.17%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to DABUR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check DABUR.NS's competition here
AMBICAAGAR.BO vs DABUR.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, DABUR.BO has a market cap of 789.9B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while DABUR.BO trades at ₹445.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas DABUR.BO's P/E ratio is 42.95. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to DABUR.BO's ROE of +0.17%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to DABUR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check DABUR.BO's competition here
AMBICAAGAR.BO vs COLPAL.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, COLPAL.NS has a market cap of 567.7B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while COLPAL.NS trades at ₹2,087.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas COLPAL.NS's P/E ratio is 42.77. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to COLPAL.NS's ROE of +0.82%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to COLPAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check COLPAL.NS's competition here
AMBICAAGAR.BO vs COLPAL.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, COLPAL.BO has a market cap of 567.7B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while COLPAL.BO trades at ₹2,087.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas COLPAL.BO's P/E ratio is 42.70. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to COLPAL.BO's ROE of +0.82%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to COLPAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check COLPAL.BO's competition here
AMBICAAGAR.BO vs PGHH.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, PGHH.NS has a market cap of 328.3B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while PGHH.NS trades at ₹10,115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas PGHH.NS's P/E ratio is 45.94. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PGHH.NS's ROE of +1.03%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to PGHH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PGHH.NS's competition here
AMBICAAGAR.BO vs PGHH.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, PGHH.BO has a market cap of 327.9B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while PGHH.BO trades at ₹10,102.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas PGHH.BO's P/E ratio is 45.64. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PGHH.BO's ROE of +1.03%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to PGHH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PGHH.BO's competition here
AMBICAAGAR.BO vs GILLETTE.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, GILLETTE.NS has a market cap of 269.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while GILLETTE.NS trades at ₹8,273.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas GILLETTE.NS's P/E ratio is 50.41. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to GILLETTE.NS's ROE of +0.58%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to GILLETTE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check GILLETTE.NS's competition here
AMBICAAGAR.BO vs GILLETTE.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, GILLETTE.BO has a market cap of 269.5B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while GILLETTE.BO trades at ₹8,271.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas GILLETTE.BO's P/E ratio is 50.60. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to GILLETTE.BO's ROE of +0.58%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to GILLETTE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check GILLETTE.BO's competition here
AMBICAAGAR.BO vs EMAMILTD.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, EMAMILTD.BO has a market cap of 174.8B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while EMAMILTD.BO trades at ₹400.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas EMAMILTD.BO's P/E ratio is 22.57. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to EMAMILTD.BO's ROE of +0.28%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to EMAMILTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check EMAMILTD.BO's competition here
AMBICAAGAR.BO vs EMAMILTD.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, EMAMILTD.NS has a market cap of 174.8B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while EMAMILTD.NS trades at ₹400.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas EMAMILTD.NS's P/E ratio is 22.54. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to EMAMILTD.NS's ROE of +0.28%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to EMAMILTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check EMAMILTD.NS's competition here
AMBICAAGAR.BO vs CUPID.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, CUPID.NS has a market cap of 173.3B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while CUPID.NS trades at ₹128.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas CUPID.NS's P/E ratio is 163.16. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to CUPID.NS's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to CUPID.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check CUPID.NS's competition here
AMBICAAGAR.BO vs CUPID.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, CUPID.BO has a market cap of 173.3B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while CUPID.BO trades at ₹128.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas CUPID.BO's P/E ratio is 163.10. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to CUPID.BO's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to CUPID.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check CUPID.BO's competition here
AMBICAAGAR.BO vs HONASA.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, HONASA.NS has a market cap of 136.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while HONASA.NS trades at ₹419.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas HONASA.NS's P/E ratio is 68.84. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HONASA.NS's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to HONASA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HONASA.NS's competition here
AMBICAAGAR.BO vs HONASA.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, HONASA.BO has a market cap of 136.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while HONASA.BO trades at ₹419.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas HONASA.BO's P/E ratio is 68.84. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HONASA.BO's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to HONASA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HONASA.BO's competition here
AMBICAAGAR.BO vs JYOTHYLAB.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, JYOTHYLAB.BO has a market cap of 76.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while JYOTHYLAB.BO trades at ₹208.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas JYOTHYLAB.BO's P/E ratio is 22.39. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to JYOTHYLAB.BO's ROE of +0.19%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to JYOTHYLAB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check JYOTHYLAB.BO's competition here
AMBICAAGAR.BO vs JYOTHYLAB.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, JYOTHYLAB.NS has a market cap of 76.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while JYOTHYLAB.NS trades at ₹208.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas JYOTHYLAB.NS's P/E ratio is 22.43. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to JYOTHYLAB.NS's ROE of +0.19%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to JYOTHYLAB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check JYOTHYLAB.NS's competition here
AMBICAAGAR.BO vs BAJAJCON.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, BAJAJCON.NS has a market cap of 73.5B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while BAJAJCON.NS trades at ₹560.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas BAJAJCON.NS's P/E ratio is 39.49. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to BAJAJCON.NS's ROE of +0.26%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to BAJAJCON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check BAJAJCON.NS's competition here
AMBICAAGAR.BO vs BAJAJCON.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, BAJAJCON.BO has a market cap of 73.2B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while BAJAJCON.BO trades at ₹560.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas BAJAJCON.BO's P/E ratio is 39.47. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to BAJAJCON.BO's ROE of +0.26%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to BAJAJCON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check BAJAJCON.BO's competition here
AMBICAAGAR.BO vs ALLTIME.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, ALLTIME.NS has a market cap of 15B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while ALLTIME.NS trades at ₹228.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas ALLTIME.NS's P/E ratio is 41.84. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to ALLTIME.NS's ROE of +0.07%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to ALLTIME.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check ALLTIME.NS's competition here
AMBICAAGAR.BO vs BCLIND.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, BCLIND.NS has a market cap of 9.7B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while BCLIND.NS trades at ₹32.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas BCLIND.NS's P/E ratio is 8.29. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to BCLIND.NS's ROE of +0.14%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to BCLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check BCLIND.NS's competition here
AMBICAAGAR.BO vs KAYA.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, KAYA.BO has a market cap of 3.7B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while KAYA.BO trades at ₹243.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas KAYA.BO's P/E ratio is -4.29. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to KAYA.BO's ROE of +0.73%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to KAYA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check KAYA.BO's competition here
AMBICAAGAR.BO vs KAYA.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, KAYA.NS has a market cap of 3.7B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while KAYA.NS trades at ₹242.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas KAYA.NS's P/E ratio is -4.27. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to KAYA.NS's ROE of +0.73%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to KAYA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check KAYA.NS's competition here
AMBICAAGAR.BO vs ADORMUL.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, ADORMUL.BO has a market cap of 1.3B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while ADORMUL.BO trades at ₹135.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas ADORMUL.BO's P/E ratio is -29.80. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to ADORMUL.BO's ROE of -0.32%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to ADORMUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check ADORMUL.BO's competition here
AMBICAAGAR.BO vs PCCOSMA.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, PCCOSMA.BO has a market cap of 854.5M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while PCCOSMA.BO trades at ₹322.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas PCCOSMA.BO's P/E ratio is 10.66. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PCCOSMA.BO's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to PCCOSMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PCCOSMA.BO's competition here
AMBICAAGAR.BO vs JHS.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, JHS.NS has a market cap of 812.9M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while JHS.NS trades at ₹9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas JHS.NS's P/E ratio is -14.76. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to JHS.NS's ROE of -0.03%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to JHS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check JHS.NS's competition here
AMBICAAGAR.BO vs JHS.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, JHS.BO has a market cap of 812M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while JHS.BO trades at ₹9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas JHS.BO's P/E ratio is -10.21. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to JHS.BO's ROE of -0.03%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to JHS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check JHS.BO's competition here
AMBICAAGAR.BO vs STDSFAC.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, STDSFAC.BO has a market cap of 434.1M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while STDSFAC.BO trades at ₹52.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas STDSFAC.BO's P/E ratio is N/A. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to STDSFAC.BO's ROE of N/A. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to STDSFAC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check STDSFAC.BO's competition here
AMBICAAGAR.BO vs AMBICAAGAR.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, AMBICAAGAR.NS has a market cap of 412.8M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while AMBICAAGAR.NS trades at ₹24.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas AMBICAAGAR.NS's P/E ratio is 32.92. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to AMBICAAGAR.NS's ROE of +0.01%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to AMBICAAGAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check AMBICAAGAR.NS's competition here
AMBICAAGAR.BO vs NKIND.NS Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, NKIND.NS has a market cap of 408M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while NKIND.NS trades at ₹67.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas NKIND.NS's P/E ratio is -6.59. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to NKIND.NS's ROE of +0.02%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to NKIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check NKIND.NS's competition here
AMBICAAGAR.BO vs NUWAY.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, NUWAY.BO has a market cap of 354.6M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while NUWAY.BO trades at ₹37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas NUWAY.BO's P/E ratio is 14.40. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to NUWAY.BO's ROE of N/A. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to NUWAY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check NUWAY.BO's competition here
AMBICAAGAR.BO vs NKIND.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, NKIND.BO has a market cap of 350.7M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while NKIND.BO trades at ₹58.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas NKIND.BO's P/E ratio is -5.67. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to NKIND.BO's ROE of +0.02%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to NKIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check NKIND.BO's competition here
AMBICAAGAR.BO vs PAOS.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, PAOS.BO has a market cap of 308.2M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while PAOS.BO trades at ₹50.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas PAOS.BO's P/E ratio is -9.55. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PAOS.BO's ROE of +0.22%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to PAOS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PAOS.BO's competition here
AMBICAAGAR.BO vs SATTVASUKU.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, SATTVASUKU.BO has a market cap of 287.7M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while SATTVASUKU.BO trades at ₹0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas SATTVASUKU.BO's P/E ratio is -75.00. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to SATTVASUKU.BO's ROE of +0.09%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to SATTVASUKU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check SATTVASUKU.BO's competition here
AMBICAAGAR.BO vs HIPOLIN.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, HIPOLIN.BO has a market cap of 284.8M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while HIPOLIN.BO trades at ₹90.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas HIPOLIN.BO's P/E ratio is -9.09. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HIPOLIN.BO's ROE of -0.35%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to HIPOLIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HIPOLIN.BO's competition here
AMBICAAGAR.BO vs PARMCOS-B.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, PARMCOS-B.BO has a market cap of 170.1M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while PARMCOS-B.BO trades at ₹35.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas PARMCOS-B.BO's P/E ratio is 318.55. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PARMCOS-B.BO's ROE of +0.00%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to PARMCOS-B.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PARMCOS-B.BO's competition here
AMBICAAGAR.BO vs CORNE.BO Comparison May 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 412.3M. In comparison, CORNE.BO has a market cap of 48M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹24.00, while CORNE.BO trades at ₹9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 82.76, whereas CORNE.BO's P/E ratio is -5.65. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to CORNE.BO's ROE of +0.09%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to CORNE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check CORNE.BO's competition here